Once-Daily Dolutegravir-Based Antiretroviral Therapy Among Adults With Advanced HIV Disease Receiving 1 Month of Daily Rifapentine and Isoniazid for Tuberculosis-Preventive Therapy and Fluconazole for

Authors: Ellis J, Hale G, Buzibye A, Omali D, Naluyima S, Ntenkaire N, Nsangi LJ, Ndyetukira JF, Sadiq A, Ahimbisibwe C, Nabbaale S, Tukundane A, Bakka W, Gakuru J, Kawuma AN, Cresswell FV, Moore DAJ, Meya DB, Boulware DR, Waitt C, Jarvis JN, Nicol MR

Journal: Open forum infectious diseases